SCHEMBL7044792

SCHEMBL7044792

COc1ccc(C(O)CNC(=O)O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.63
ALDH1A1 P00352 3/20 0.59
MAPT P10636 1/20 0.59
GAA P10253 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
KDM4E B2RXH2 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
BCAT2 O15382 1/20 0.47
CNR2 P34972 2/20 0.47
CNR1 P21554 1/20 0.47
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
LDHA P00338 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8581724 0.87 AOC3 (0.63) AOC3ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL31232828 0.83 NPC1 (0.72) AOC3ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL30644009 0.83 NPC1 (0.72) AOC3ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL4583429 0.82 CYP1A2 (0.51) AOC3ALDH1A1MAPTSMN1; SMN2KDM4E
SCHEMBL5065146 0.81 AOC3 (0.67) AOC3GAATDP1MTNR1AMTNR1B
SCHEMBL1554809 0.79 CA1 (0.58) AOC3ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL3649469 0.79 TAAR1 (0.58) ALDH1A1SMN1; SMN2KDM4ETDP1BCAT2
SCHEMBL9179848 0.79 AOC3 (0.71) AOC3ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL8379013 0.79 TAAR1 (0.58) ALDH1A1SMN1; SMN2KDM4ETDP1BCAT2
SCHEMBL8379019 0.79 TAAR1 (0.58) ALDH1A1SMN1; SMN2KDM4ETDP1BCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299103-A1 4,5-DIHYDRO-THIAZO-2-YLAMINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS Aventis Pharma S.A. (FR) 2003-04-09 EP disclosed
WO-2001093867-A1 4,5-DIHYDRO-THIAZO-2-YLAMINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2001-12-13 WO disclosed